Cafepharma Today

July 3 2025 - Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
AstraZeneca board
Intuitive Surgical’s da Vinci 5 robot wins CE mark
Intuitive Surgical board
Novartis drug flunks phase 3 test in giant cell arteritis
Novartis board
Bluebird go-private deal signals the ‘PE-ization of pharma’
General Pharma Discussion board
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

As BioMarin searches for 'clever science,' its R&D chief warns innovation could be hit by NIH fund drought
Fierce Biotech
Friday, February 21, 2025 - 10:53am
tags:
Biomarin, R&D, NIH
Device industry scrambles amid concern FDA layoffs will cause delays
BioPharma Dive
Friday, February 21, 2025 - 10:52am
tags:
Medtech, devices, FDA, CDRH
Pfizer Axes Beqvez Worldwide, Pivoting Away From Gene Therapy for Hemophilia
BioSpace
Friday, February 21, 2025 - 10:51am
tags:
Pfizer, Beqvez, gene therapy, hemophila B
Boehringer and partners commence gene therapy trial for cystic fibrosis
Clinical Trials Arena
Friday, February 21, 2025 - 10:49am
tags:
Boehringer Ingelheim, gene therapy, cystic fibrosis, clinical trials
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
CNBC
Friday, February 21, 2025 - 10:48am
tags:
FDA, drug shortages, Novo Nordisk, Ozempic, Wegovy
Bluebird, at risk of default, agrees to take-private deal
BioPharma Dive
Friday, February 21, 2025 - 10:47am
tags:
Bluebird Bio, M&A, Carlyle Group, SK Capital, gene therapy
Dr. Albert Bourla of Pfizer Becomes New Chair of PhRMA Board
PhRMA
Friday, February 21, 2025 - 10:11am
tags:
Pfizer, Pharma CEOs, Albert Bourla, PhRMA
FDA staffers told that 'woman,' 'disabled' among banned words - White House says it’s an error
MSN
Friday, February 21, 2025 - 10:10am
tags:
FDA, Donald Trump, Women's Health
CDC vaccine meeting, set to be first since RFK Jr. sworn in, is postponed
BioPharma Dive
Friday, February 21, 2025 - 10:06am
tags:
CDC, vaccines, Robert F Kennedy Jr., HHS
Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile
US News and World Report
Thursday, February 20, 2025 - 6:07pm
tags:
Eli Lilly, weight loss, obesity, clinical trials, orforglipron
5 Things Medtech Is Talking About in February
Medical Devices and Diagnostics Industry
Thursday, February 20, 2025 - 6:03pm
tags:
layoffs, Donald Trump, Robert F Kennedy Jr., HHS, Medtech, tariffs, JNJ
U.S. Facing Critical Hospital Bed Shortage
US News and World Report
Thursday, February 20, 2025 - 5:43pm
tags:
hospitals, Public Health
Roche unveils its breakthrough proprietary SBX sequencing technology
Tip Ranks
Thursday, February 20, 2025 - 5:39pm
tags:
Roche, Medtech, DNA sequencing, SBX sequencing
US biotech Hookipa retracts merger plans with UK company
Fierce Biotech
Thursday, February 20, 2025 - 5:36pm
tags:
Hookipa Pharma, M&A, Poolbeg Pharma
AstraZeneca deepens China presence with FibroGen deal
BioPharma Dive
Thursday, February 20, 2025 - 11:52am
tags:
AstraZeneca, FDA, FibroGen, China, roxadustat
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV
Clinical Trials Arena
Thursday, February 20, 2025 - 11:51am
tags:
Precision Biosciences, clinical trials, hepatitis B, PBGENE-HBV, gene editing
Trump administration yanks CDC flu vaccine campaign
NPR
Thursday, February 20, 2025 - 11:49am
tags:
Donald Trump, vaccines, CDC, Flu
Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars
Yahoo Finance
Thursday, February 20, 2025 - 11:40am
tags:
Baxter International, Medtech, earnings
Bristol Myers Squibb notches overall survival win with Opdivo in preoperative NSCLC
Fierce Pharma
Thursday, February 20, 2025 - 11:38am
tags:
Bristol Myers Squibb, Opdivo, non-small cell lung cancer, clinical trials
Insurers push back on Medicare and Medicaid coverage for GLP-1s
Axios
Thursday, February 20, 2025 - 11:37am
tags:
insurers, Medicare, Medicaid, obesity, Novo Nordisk, Eli Lilly, Mounjaro, Wegovy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Assays Are Always Welcome
In the Pipeline
Down In the Reaction Details
In the Pipeline
The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.